Michiel S. Van Der Heijden, Michal Sarfaty, Christian Caglevic, Marine Gross-Goupil, Eli Rosenbaum, Jae Lyun Lee, Thomas Powles, Srikala S. Sridhar, Carlos Rojas, Sang Joon Shin, Debbie G.J. Robbrecht, Javier Puente, Rafael Morales-Barrera, Wen-Pin Su, Yu-Li Su, Denis Maillet, April Wang, Abhishek Amar Bavle, Blanca Homet Moreno, Avivit Peer. "KEYMAKER-U04 substudy 04B: First-line (1L) enfortumab vedotin (EV) plus pembrolizumab (pembro)-based immune checkpoint inhibitor (ICI) combinations for advanced urothelial cancer (UC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.634